Kenneth Song

Kenneth Song

Plus aucun poste en cours

49 ans
Finance
Commercial Services
Health Technology

Profil

Kenneth Song was the founder and the Chief Executive Officer of Ariosa Diagnostics, Inc., which was founded in 2008.
He was the President, Chief Executive Officer & Director of Metacrine, Inc. from 2016 to 2020.
From 2020 to 2024, he held the same positions at Rayzebio, Inc. Dr. Song served as the Executive Chairman of Omniome LLC from 2017 to 2021.
He was also a Vice President at Venrock Associates from 2007 to 2010.
Additionally, Dr. Song worked as a Consultant at McKinsey & Co., Inc. Dr. Song obtained his undergraduate degree from the Massachusetts Institute of Technology and his doctorate degree from The University of California, San Francisco.

Anciens postes connus de Kenneth Song

SociétésPosteFin
RAYZEBIO, INC. Chief Executive Officer 26/02/2024
Chairman 01/09/2021
METACRINE, INC. Chief Executive Officer 09/06/2020
Private Equity Analyst 01/01/2010
Corporate Officer/Principal -
Voir l'expérience en détail de Kenneth Song

Formation de Kenneth Song

Massachusetts Institute of Technology Undergraduate Degree
The University of California, San Francisco Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Kenneth Song

Relations

93

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
RAYZEBIO, INC.

Health Technology

METACRINE, INC.

Health Technology

Entreprise privées4

Finance

Commercial Services

Commercial Services

Health Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Kenneth Song